Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Characterization of Leading Somatic Pathologies in Pediatric Patients: Optimizing Treatment and Medical Rehabilitation Strategies

NCT06267859 is registered in ClinicalTrials.gov with Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan as lead sponsor.

NCT NCT06267859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06267859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Characterization of Leading Somatic Pathologies in Pediatric Patients: Optimizing Treatment and Medical Rehabilitation Strategies
Lead sponsor
Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
November 8, 2023
Completion date
January 30, 2034
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart defects, respiratory diseases